Metrics And Analytics
Clinical Trial Efficiency: Top Risk Indicators and Solutions for Site Performance
Monitor four critical metrics across your sites to prevent persistent challenges to clinical trials
Our OnCore CTMS Vision: Building a Foundation for Success
More than two decades ago, we created OnCore CTMS. What do we have in store for the future?
Operationalizing Research Analytics: Today, Tomorrow, Someday
Uncover how analytics, artificial intelligence, and machine learning are reshaping the foundational elements of clinical research.
Unlocking Study Activation: 2023 Study Activation Report
Access the survey report now for current perspectives on study startup activities impacted by rapidly evolving technology and tools.
What is a Data Monitoring Committee?
In a complex clinical trial, data monitoring committees oversee interim data to ensure adequate safety monitoring.
Improving Study Activation Time for Gene Therapy Research
With the growing popularity of gene therapy research and genetically engineered vaccines, sites need to understand study activation impacts
4 Modernized Functions Every Sponsor Needs for Study Startup
This white paper outlines four technology capabilities sponsors need to expedite the study startup process.
Data on the go: Mobile Application Considerations for Clinical Trials and Beyond
Find out the necessary regulatory and ethical considerations when utilizing an app or connected device in human subjects research.
University of Nebraska Medical Center Streamlines Regulatory Management and Accelerates Study Startup with Advarra eReg
Learn how Advarra eReg helps UNMC support remote monitoring and how eReg helped address prevalent challenges in clinical research.
Privacy and Confidentiality in the Age of Mobile Apps and Connected Devices
Discover how to protect participant privacy in mobile-app-based clinical research. Learn about risks and what IRBs need to consider in protocol review.
Top 3 Reasons Why Your Medical Device Needs a Clinical Trial
Interpreting evolving regulations for medical devices is a common challenge for emerging biotech companies.
Multiple Dynamic Endpoints and the Role of Endpoint Adjudication Committees in Clinical Trials
Trial designs incorporating multiple endpoints to support efficacy are receiving increased focus from the FDA, including a recently published guidance.